| Characteristics |
Bivariate analysis |
Multivariate analysis |
| Crude HR (95% CI) |
P value |
Adjusted HR (95% CI) |
P value |
| Age (years) |
| Per 1 yr increase |
0.7 (0.64-0.91) |
0.003 |
0.76 (0.62-0.94) |
0.01 |
| >5.0 |
1.00 (Ref) |
- |
- |
- |
| <5.0 |
3.45 (1.20, 9.94) |
0.02 |
- |
- |
| Sex |
| Female |
1.00 (Ref) |
|
0.03 |
|
| Male |
2.42 (1.07, 5.50) |
- |
- |
- |
| Pulmonary TB |
| No |
1.00 (Ref) |
|
- |
- |
| Yes |
2.16 (0.75, 6.22) |
0.15 |
- |
- |
| Cotrimoxazole prophylaxis |
| Yes |
1.00 (Ref) |
- |
|
|
| No |
0.78 (0.27, 2.26) |
0.65 |
- |
- |
| Thrush |
| No |
1.00 (Ref) |
- |
- |
- |
| Yes |
2.23 (0.53, 9.34) |
0.28 |
- |
- |
| WHO clinical Stage |
| 1 or 2 |
100 (Ref) |
- |
- |
- |
| 3 or 4 |
1.58 (0.74, 3.37) |
0.24 |
- |
- |
| Weight-for-age Z score |
| >-3.0 |
1.00 (Ref) |
- |
- |
- |
| <-3.0 |
2.11 (1.0, 4.5) |
0.05 |
- |
- |
| Haemoglobin level (g/dL) |
| <8 g/dL |
1.00 (Ref) |
- |
- |
- |
| >8 g/Dl |
1.58 (0.37, 6.74) |
0.53 |
- |
- |
| Severe immunodeficiency |
| No |
1.00 (Ref) |
- |
- |
- |
| Yes |
1.92 (0.83, 4.44) |
0.13 |
- |
- |
|
